A critical breakthrough in cancer study is arising with the use of VHH fragments to re-engage damaged p53. This crucial cancer inhibitor protein is frequently disabled in several types of tumors, leading uncontrolled https://sociallytraffic.com/story6986115/mini-antibodies-restore-tumor-suppressor-p53-new-new-approach-for-cancer-management